AmdocsFRA:AOS +0.78%77 9-Day RSI is 35.46 as of Jul. 04, 2026. GuruFocus rates FRA:AOS with a GF Score™ of 77/100 and a GF Value™ of €75.78 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 2,927 Software companies, Amdocs ranks better than 73.93% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-04), Amdocs's 9-Day RSI is 35.46.
The industry rank for Amdocs's 9-Day RSI or its related term are showing as below:
FRA:AOS's 9-Day RSI is ranked better than 73.93% of 2927
companies
in the Software industry
Industry Median: 48.5
vs FRA:AOS: 35.46
Amdocs (FRA:AOS) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Amdocs 9-Day RSI Related Terms
FRA:AOS vs PATH, S, ACIW: 9-Day RSI Comparison
For the Software - Infrastructure subindustry, Amdocs's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amdocs 9-Day RSI vs Software Industry
For the Software industry and Technology sector, Amdocs's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Amdocs's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amdocs (FRA:AOS) has a 9-Day RSI of 35.46 as of Jul. 04, 2026. According to the industry distribution chart, Amdocs ranks #763 out of 2927 companies in the Software industry, placing it in the top 26.1%.
Is Amdocs' 9-Day RSI too high?
Amdocs' current 9-Day RSI is 35.46. The Software industry median 9-Day RSI is 48.50. Amdocs' value of 35.46 is 26.9% below this industry median. Based on the distribution chart, Amdocs ranks #763 out of 2927 companies in the Software industry, which is above the industry midpoint. Overall, Amdocs has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Amdocs' 9-Day RSI compare to PATH and S?
According to the Software industry distribution chart, Amdocs ranks #763 out of 2927 companies for 9-Day RSI. This puts Amdocs in the upper half of its industry. The industry median 9-Day RSI is 48.50. Amdocs' value of 35.46 is 26.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Software company?
The median 9-Day RSI among Software companies is 48.50, based on 2,927 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amdocs's current 9-Day RSI of 35.46 is 26.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Software industry, the median 9-Day RSI is 48.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amdocs's current 9-Day RSI is 35.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amdocs stock overvalued right now?
Based on GuruFocus' analysis, Amdocs (FRA:AOS) is currently considered Significantly Undervalued. The stock's GF Value™ is €75.78, compared to a current price of €44.95 — trading 40.7% below its estimated fair value. The current 9-Day RSI is 35.46 and 26.9% below the Software industry median of 48.50. Amdocs' overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Amdocs (FRA:AOS), the current 9-Day RSI is 35.46 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Amdocs (FRA:AOS) Overvalued in 2026?
Based on GuruFocus' analysis, Amdocs stock appears to be undervalued.
The current stock price of €44.95 is trading 40.7% below its estimated GF Value™ of €75.78.
GuruFocus considers Amdocs to be Significantly Undervalued.
Key valuation signals for FRA:AOS:
9-Day RSI: 35.46
GF Value™: €75.78 vs. price of €44.95 (40.7% below fair value)
Industry Position: 26.9% below the Software median (#763 of 2927)
No single metric tells the full story. See the FRA:AOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Amdocs Ltd is a provider of software and services to communications, entertainment, and media service providers. The Company operates in a single segment and designs, develops, markets, supports, implements, and operates open and modular cloud offerings. Its portfolio includes solutions across digital business systems and legacy business and operational support systems, supporting multiple lines of business such as wireless, broadband, cable, fiber, satellite, and digital services. The Company leverages artificial intelligence to support digital transformation, cloud adoption, and intelligent network automation. Geographically, it derives a majority of its revenue from North America and also operates in Europe and the rest of the world.
77GF Score
Get the complete analysis for FRA:AOS
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AOS has been successfully added to your 